As of 12:31 PM on the 18th, Celltrion is trading at 294,000 KRW, up 0.86% from the previous day. This is a 7.55% decrease compared to September 8. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 13,759 shares of Celltrion, and institutions have net sold 12,000 shares, according to provisional data. Over the past five days, individual investors have net bought 178,166 shares, while foreigners and institutions have net sold 125,279 shares and 131,840 shares, respectively.
On September 16, Celltrion was a market topic for its "strength due to the news of a biosimilar drug supply contract."


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
